Stock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns

Stock Track04-09

ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.

The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a "Neutral" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.

Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1141985297?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-09 15:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141985297","market":"hk","top_or_hot":-1,"title":"Stock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns","media":"Stock Track","content":"<p>ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.</p><p>The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a \"Neutral\" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.</p><p>Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-09 15:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.</p><p>The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a \"Neutral\" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.</p><p>Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1141985297","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141985297","pubTimestamp":1775721208,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.The decline followed a report from Goldman Sachs which lowered its target price for ALI...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"个股赛道|阿里健康盘中暴跌5.10%高盛因AI和药物投资担忧下调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a \"Neutral\" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1141985297","isCrawlerRequest":true}